Nutriband Inc.

Contributing Author

Recent Articles by Nutriband Inc.

Jan-30	Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points NTRB +5.97% GlobeNewswire
Dec-31	Nutriband CEO Publishes Letter to Shareholders NTRB GlobeNewswire
Dec-29	Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio NTRB GlobeNewswire
Dec-18	Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration NTRB GlobeNewswire
Dec-18	Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction NTRB GlobeNewswire
Oct-28	REPEAT - Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch NTRB GlobeNewswire
Oct-28	Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch NTRB GlobeNewswire
Oct-27	Nutriband Co-Founder Gareth Sheridan Returns as CEO NTRB GlobeNewswire
Oct-10	Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch NTRB GlobeNewswire
Oct-08	Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology NTRB GlobeNewswire
Oct-08	Nutriband To Present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference NTRB GlobeNewswire
Sep-24	Nutriband Inc. to Present at the MicroCap Rodeo Conference NTRB GlobeNewswire
Sep-10	Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl NTRB GlobeNewswire
Sep-03	Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000 NTRB GlobeNewswire
Aug-18	Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025 NTRB GlobeNewswire
Aug-11	Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election NTRB GlobeNewswire
Aug-08	FDA Grants Nutriband Meeting Request for Aversa Fentanyl Abuse Deterrent Fentanyl Patch NTRB GlobeNewswire
Jul-18	Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval NTRB GlobeNewswire
Jul-02	Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval NTRB GlobeNewswire
Jul-01	Nutriband Inc. added to the Russell Microcap Index, Russell Microcap Growth Index, Russell 3000E Index and Russell 3000E Growth Index NTRB GlobeNewswire
Jun-18	Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa Fentanyl Abuse Deterrent Fentanyl Patch NTRB GlobeNewswire
Jun-09	Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology NTRB GlobeNewswire
Jun-03	Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference NTRB GlobeNewswire
Jun-02	Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl NTRB GlobeNewswire

Nutriband Inc.

Recent Articles by Nutriband Inc.

Upgrade your FINVIZ experience